Reuters, 11 Feb 2009, Kevin Lim
SINGAPORE, Feb 11 (Reuters) - Singapore Exchange (SGXL.SI) on Wednesday published a set of proposed rules that will allow life sciences firms to list shares on its Catalyst board even if they have not begun commercial activities.
Such firms must, however, have sponsors with access to technical expertise who can advise investors on developments within the company, SGX said in a statement.
Read More
